Ionis Pharmaceuticals Inc (IONS) Price Prediction & ForecastIONSIonis Pharmaceuticals Inc

Alphio's IONS stock price prediction model matches the current Ionis Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $44.43 (+0.37%). The 1-week path is $44.15 (-0.26%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Ionis Pharmaceuticals is currently not a strong buy. The stock is trading at $42.94, which is significantly below its 200-day simple moving average of $68.60, indicating a bearish trend. Additionally, the RSI is at 41.83, suggesting that the stock is nearing oversold territory but not yet a clear buy signal. The forward P/E ratio is extremely high at 90.91, indicating that the stock may be overvalued based on future earnings expectations. Furthermore, the company reported a significant year-to-date decline of 46.10%, which raises concerns about its short-term performance. The main risk is the recent negative sentiment reflected in analyst downgrades and competitive pressures, particularly from Alnylam, which reported a 41% revenue decline for Ionis compared to its own 74% growth.

Ionis Pharmaceuticals Inc (IONS) last closed at $44.27, losing -2.49%. These facts feed the 1-day and 1-week IONS price prediction above.